+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiomyopathy Drug"

Dilated Cardiomyopathy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Dilated Cardiomyopathy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 159 Pages
  • Global
From
Restrictive Cardiomyopathy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Restrictive Cardiomyopathy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 123 Pages
  • Global
From
Genetic Cardiomyopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Genetic Cardiomyopathies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Dilated Cardiomyopathy Market by Drug Class Inhibitors, Treatment Type, Route of Administration, Distribution Channel, and By Region - Product Thumbnail Image

Dilated Cardiomyopathy Market by Drug Class Inhibitors, Treatment Type, Route of Administration, Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Dilated Cardiomyopathy Therapeutic Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Dilated Cardiomyopathy Therapeutic Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 112 Pages
  • Global
From
Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • June 2022
  • 101 Pages
  • Global
From
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 80 Pages
  • Global
From
Cardiomyopathies Epidemiology Forecast, 2021-2031 - Product Thumbnail Image

Cardiomyopathies Epidemiology Forecast, 2021-2031

  • Report
  • June 2022
  • 38 Pages
  • Global
From
Arrhythmogenic Cardiomyopathy (ACM) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Arrhythmogenic Cardiomyopathy (ACM) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • October 2023
  • 26 Pages
  • Global
Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 81 Pages
  • Global
From
Dilated Cardiomyopathy Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Dilated Cardiomyopathy Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 109 Pages
  • Global
From
Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 87 Pages
  • Global
From
Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 37 Pages
  • Global
From
Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 122 Pages
  • Global
From
Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 40 Pages
  • Global
From
Loading Indicator

The Cardiomyopathy Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat cardiomyopathy, a condition in which the heart muscle becomes weakened or damaged. These drugs are used to reduce symptoms, improve heart function, and reduce the risk of complications. Commonly used drugs include beta-blockers, ACE inhibitors, angiotensin receptor blockers, and diuretics. Other treatments may include lifestyle changes, such as diet and exercise, and surgery. The Cardiomyopathy Drug market is highly competitive, with many companies offering a variety of treatments. Major players in the market include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Other companies include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more